USD 26.8
(-4.76%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 32.33 Million USD | -30.47% |
2022 | 46.5 Million USD | 167.34% |
2021 | 17.39 Million USD | 11.4% |
2020 | 15.61 Million USD | 61.92% |
2019 | 9.64 Million USD | 23.36% |
2018 | 7.81 Million USD | 331.16% |
2017 | 1.81 Million USD | 37.77% |
2016 | 1.31 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 27.86 Million USD | -10.92% |
2024 Q1 | 31.27 Million USD | -3.27% |
2023 Q4 | 32.33 Million USD | -5.25% |
2023 Q1 | 32.89 Million USD | -29.26% |
2023 Q2 | 26.02 Million USD | -20.88% |
2023 Q3 | 34.12 Million USD | 31.12% |
2023 FY | 32.33 Million USD | -30.47% |
2022 Q2 | 77.76 Million USD | -2.97% |
2022 Q1 | 80.14 Million USD | 360.77% |
2022 FY | 46.5 Million USD | 167.34% |
2022 Q4 | 46.5 Million USD | -28.07% |
2022 Q3 | 64.65 Million USD | -16.87% |
2021 Q2 | 19.59 Million USD | 26.44% |
2021 Q1 | 15.49 Million USD | -0.74% |
2021 FY | 17.39 Million USD | 11.4% |
2021 Q4 | 17.39 Million USD | 0.21% |
2021 Q3 | 17.35 Million USD | -11.42% |
2020 Q1 | 15.96 Million USD | 65.54% |
2020 Q2 | 18.81 Million USD | 17.87% |
2020 Q3 | 17.14 Million USD | -8.87% |
2020 Q4 | 15.61 Million USD | -8.94% |
2020 FY | 15.61 Million USD | 61.92% |
2019 Q2 | 9.95 Million USD | 13.87% |
2019 FY | 9.64 Million USD | 23.36% |
2019 Q4 | 9.64 Million USD | 10.08% |
2019 Q3 | 8.76 Million USD | -11.99% |
2019 Q1 | 8.74 Million USD | 11.82% |
2018 Q3 | 9.22 Million USD | 8.02% |
2018 Q4 | 7.81 Million USD | -15.3% |
2018 Q2 | 8.54 Million USD | 8.12% |
2018 FY | 7.81 Million USD | 331.16% |
2018 Q1 | 7.9 Million USD | 335.85% |
2017 Q1 | 1.49 Million USD | 13.6% |
2017 Q3 | 1.4 Million USD | -7.83% |
2017 Q4 | 1.81 Million USD | 29.41% |
2017 Q2 | 1.52 Million USD | 1.67% |
2017 FY | 1.81 Million USD | 37.77% |
2016 Q4 | 1.31 Million USD | -16.5% |
2016 Q3 | 1.57 Million USD | 29.82% |
2016 Q2 | 1.21 Million USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | 1.31 Million USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -575.123% |
Safety Shot Inc | 1.86 Million USD | -1629.31% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 78.743% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 70.923% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -377.648% |
Dynavax Technologies Corporation | 53.29 Million USD | 39.328% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 50.731% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -177.599% |
Pacira BioSciences, Inc. | 104.35 Million USD | 69.017% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -463.79% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -463.79% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -3892.803% |
Journey Medical Corporation | 10.2 Million USD | -216.794% |
Alpha Teknova, Inc. | 11.59 Million USD | -178.868% |
Procaps Group, S.A. | 96.83 Million USD | 66.611% |
Theratechnologies Inc. | 6.06 Million USD | -433.004% |
Harrow Health, Inc. | 10.86 Million USD | -197.525% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -1089.114% |
Biofrontera Inc. | 10.9 Million USD | -196.406% |
DURECT Corporation | 2.21 Million USD | -1357.053% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 58.232% |
Cronos Group Inc. | 30.33 Million USD | -6.569% |
OptiNose, Inc. | 8.05 Million USD | -301.54% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -3233199900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -467.324% |
Organogenesis Holdings Inc. | 28.25 Million USD | -14.437% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -1107.719% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -601.442% |
Radius Health, Inc. | 278.64 Million USD | 88.397% |
Universe Pharmaceuticals INC | 3.34 Million USD | -867.078% |
ProPhase Labs, Inc. | 3.84 Million USD | -741.76% |
Phibro Animal Health Corporation | 265.91 Million USD | 87.841% |
Procaps Group S.A. | 96.83 Million USD | 66.611% |
Alvotech | 74.43 Million USD | 56.562% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.068% |
Rockwell Medical, Inc. | 5.87 Million USD | -450.707% |
Aytu BioPharma, Inc. | 12.63 Million USD | -155.933% |
SIGA Technologies, Inc. | 64.21 Million USD | 49.653% |
Tilray Brands, Inc. | 252.08 Million USD | 87.174% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 19.128% |
Shineco, Inc. | 1.58 Million USD | -1935.347% |
PetIQ, Inc. | 159.3 Million USD | 79.705% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 21262.733% |
Incannex Healthcare Limited | -10.01 Million USD | 422.836% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 15.582% |
Alimera Sciences, Inc. | 1.87 Million USD | -1620.703% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 14.207% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -1907.711% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -621.213% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -12611.518% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -211.484% |
Hempacco Co., Inc. | 2.54 Million USD | -1171.598% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 56.562% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 32.351% |
Lantheus Holdings, Inc. | 64.02 Million USD | 49.504% |
Currenc Group, Inc. | 732.91 Thousand USD | -4311.45% |
Kamada Ltd. | 87.74 Million USD | 63.153% |
Indivior PLC | 141.79 Million USD | 77.199% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -6610.111% |
Flora Growth Corp. | 8.5 Million USD | -280.019% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -12611.518% |
Evolus, Inc. | 10.99 Million USD | -193.981% |
HUTCHMED (China) Limited | 50.25 Million USD | 35.668% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 69.45% |
Akanda Corp. | 1.28 Million USD | -2412.406% |